Resources for Health Professionals


Mebendazole*, is the drug of choice for adults, 200 mg orally twice a day for 20 days; the pediatric dosage is the same.


Albendazole*, adults, 400 mg orally once a day for 10 days; the pediatric dosage is the same.

(Note: Albendazole must be taken with food; a fatty meal increases oral bioavailability.)

Oral mebendazole is available for human use in the United States

Oral albendazole is available for human use in the United States.

*Not FDA-approved for this indication.


  • Li CD, Yang HL, Wang Y. Capillaria hepatica in China. World J Gastroenterol. 2010 Feb 14;16(6):698-702.
  • Drugs for Parasitic Infections. Treatment Guidelines from the Medical Letter. Vol 8 (Suppl), 2010. The Medical Letter, Inc., New Rochelle, NY.
  • Cañete R, Escobedo AA, Almirall P, González ME, Brito K, Cimerman S. Mebendazole in parasitic infections other than those caused by soil-transmitted helminths. Trans R Soc Trop Med Hyg 2009;103:437-42.
  • Moore TA. Agents active against parasites and pneumocystis , Table 44-1-General recommendations for the treatment of parasitic infections. In: Mandell GL, Bennett JE, Dolin R, Eds., Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 7th Ed, Churchill Livingston/Elsevier, Philadelphia, PA, 2009.
  • Soukhathammavong P, Sayasone S, Harimanana AN et al. Three cases of intestinal capillariasis in Lao People’s Democratic Republic. Am J Trop Med Hyg 2008;Nov;79(5):735-8.
  • Guerrant RL, Walker DH, Weller PF (eds). Tropical Infectious Diseases: Principles, Pathogens, and Practice, 2nd Edition. Philidelphia 2006, pp 1242-1244.
  • Bair MJ, Hwang KP, Wang TE et al. Clinical features of human intestinal capillariasis in Taiwan. World J Gastroenterol 2004 Aug 15;10(16):2391-3.

This information is provided as an informational resource for licensed health care providers as guidance only. It is not intended as a substitute for professional judgment.



Page last reviewed: May 20, 2020